Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial

Authors: Patrick Schöffski, Sant P. Chawla, Robert G. Maki, Antoîne Italiano, Hans Gelderblom, Edwin Choy, Giovanni Grignani, Veridiana Pires de Camargo, Sebastian Bauer, Sun Young Rha, Jean‐Yves Blay, Peter Hohenberger, David R. D’Adamo, Matthew Guo, Bartosz Chmielowski, Axel Le Cesne, George D. Demetri, Shreyaskumar Patel - The Lancet 2016 cited by 766